Child receiving a vaccine jab

First children’s vaccine trial for Covid-19 opens

Following the vaccination of more than 15 million people with at least their first jab across the UK, the first study to assess the safety and immune response of the Covid-19 vaccine in children and young adults is set to begin.

The study, which will be funded and supported by NIHR and run by the University of Oxford, will focus on using the Oxford vaccine - currently approved and being given to adults by the NHS.

Building on previous clinical trials of the vaccine, which have shown it to be safe, produce a strong immune system response and have high efficacy levels in all adults, this new trial will assess whether children and young adults, from 6-17 years of age, also display a good immune response to the vaccine.

It will seek to enrol 300 volunteers and operate as a single-blind, randomised phase II trial. Of those who volunteer, up to 240 will receive the Oxford vaccine while the remainder receive a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as soreness at the injection site.

To improve the pool of participants they could recruit, the researchers will work together with three partner sites in London, Southampton and Bristol.

Professor Andrew Pollard, Professor of Paediatric Infection and Immunity and Chief Investigator on the Oxford vaccine trial, said: "While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.

“These new trials will extend our understanding of control of SARS-CoV2 to younger age groups."

Dr William van’t Hoff, Chief Executive of NIHR’s Clinical Research Network, added: "We’ve already seen the contribution of Covid-19 vaccine research in the UK to protecting adults.

“I’m delighted the launch of this trial will extend our knowledge of how to protect children and young adults in the future."

The trial officially launched on February 13, 2021 and the first vaccinations are expected during the month of February.

Further information on the trial, including how to sign up, can be found by visiting here.

NHE May/June 22

NHE May/June 22

Developing a high-quality NHS estate

The new edition of NHE’s e-magazine highlights the latest in cyber security, pharmaceuticals, NHS workforce, NHS Estates, driving innovation in procurement and more with articles from the likes of Brendan Griffin-Ryan, Senior Category Manager, Estates & Facilities, NHS SBS (pg79), West London NHS Trust and Health Education England.

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all